Evaluation of Label Drug in the Treatment Polycystic Ovary Syndrome
Abstract
Objectives: Polycystic ovary syndrome (PCOS) is defined as high levels of hyperandrogenism, menstrual irregularities, anovulation and high levels of insulin (hyperinsulinemia secondary to increased insulin resistance).The estimated that> 75% of women with PCOS are insulin resistant, the incidence of PCOS affects 4% -8% of reproductive-aged women. The aims of this study to an evaluation of metformin treatment of PCOS. This research was a cross-sectional study with prospective data collection conducted From January to May 2019. Data from 16 participants were involved in this study, with the criteria inclusion. Data were processed statistically using Paired Sample T-test analysis to determine the effectiveness and side effects of metformin. There was a significant difference between the thickening of the endometrium before and after metformin treatment (P 0.001 <0.005). In observing the side effects, it was found that the use of metformin treatment was seen from random plasma glucose measurements on day 0, 3, 6 and 9 obtained (P 0.009<0.005) there were significant differences between the groups of random plasma glucose measurement days 0, 3, 6 and 9.
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 16 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.